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Abstract
The inability to identify, isolate, and culture intestinal epithelial stem cells (IESCs) has been prohibitive to
the study and therapeutic utilization of these cells. Using a Sox9  mouse model, we demonstrate that
Sox9  fluorescence signatures can be used to differentiate between and enrich for progenitors
(Sox9 ) and multipotent IESCs (Sox9 ). Sox9  cells generate “organoids” in a recently
defined culture system that mimics the native IESC niche. These organoids possess all four differentiated
cell types of the small intestine epithelium, demonstrating the multipotent capacity of Sox9  cells.
Our results are consistent with the previously reported observation that single IESCs generate cryptlike
units without a detectable mesenchymal cell component. A prospective search revealed that CD24 is
expressed in the Sox9  population and marks IESCs that form organoids in culture. CD24 represents
the first cell surface marker that facilitates fluorescence-activated cell sorting enrichment of IESCs with
widely available antibodies without requiring a specialized fluorescent reporter gene mouse model.
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ඍඋൺඇඌඅൺඍංඈඇൺඅ ඁං඀ඁඅං඀ඁඍඌ Isolation and culture of intestinal epithelial stem cells (IESCs) remains a
challenge. This paper uses differential expression levels of a Sox9EGFP reporter to FACS isolate IESCs,
and as a tool to identify CD24 FACS gates that would allow enrichment for IESCs using widely available
antibodies. Single “low-expressing” Sox9EGFP cells and CD24 cells gave rise to “organoids” containing
all differentiated cell types of the epithelium. These data demonstrate that low-expressing Sox9EGFP are
functional IESCs and that CD24 functions as a new cell surface marker permitting enrichment for IESCs
from a nonfluorescent reporter gene mouse.
ඍඁൾ ංඇඍൾඌඍංඇൺඅ ൾඉංඍඁൾඅංඎආ is one of the most proliferative tissues in the mammalian organism. The entire
monolayer of epithelium is replaced approximately every 7 days (6, 11), and this renewal process is driven
by a pool of multipotent, self-renewing stem cells that are positioned between Paneth cells and also
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immediately above the Paneth cell compartment in the base of the crypt (4, 35). Typically, in the adult
organism stem cells are thought to undergo an asymmetric division process that generates a larger pool of
more rapidly dividing transit-amplifying populations (or progenitors) that are located higher up the crypt-
villus axis toward the lumen (6, 11). Intrinsic and extrinsic signaling directs these progenitors to commit to
one of four functionally distinct postmitotic cell types: the enterocyte (absorptive) (9), goblet cell (mucus
producing) (7), enteroendocrine cell (hormone producing) (10), and Paneth cell (antimicrobial peptide
producing) (8). With the exception of the Paneth cell population, the other three cell types migrate up the
crypt-villus axis and are sloughed into the lumen at the villus tip. Paneth cells are born around cell position
+5 (as numbered from the base of the crypt toward the lumen) and migrate down to the crypt base, where
they secrete antimicrobial peptides into the crypt lumen (8). Normal gut homeostasis is critically reliant on
the proper control of stem cell proliferation, division, and subsequent generation of the transit-amplifying
progenitor pool.
Significant progress toward identifying, isolating, and manipulating the intestinal epithelial stem cell
(IESC) has been hindered by the lack of specific IESC biomarkers and suitable culturing techniques.
Recently, a number of putative IESC biomarkers have been identified, but relatively few of these
biomarkers have been tested to confirm that cells expressing these biomarkers pass the test of multipotency
and self-renewal, the two functional characteristics that define a stem cell. Three studies have employed
Cre-recombinase-mediated genetic lineage-tracing technology, currently the most rigorous method to
assess multipotency in vivo, to demonstrate that the biomarkers Lgr5, Bmi1, and CD133/prominin1 are
expressed in cell populations that demonstrate multipotency and self-renewal capacity in the small intestine
(4, 35, 39). The expression patterns of Lgr5, Bmi1, and CD133/prominin1 mark stem cell populations that
are differentially positioned in distinct regions of the crypt. Lgr5 expression is restricted primarily to the
crypt-based columnar cells (CBC) that are intercalated between the Paneth cells (4). Bmi1 also shows a
highly restricted expression pattern that is primarily localized to the supra-Paneth cell region, the zone
typically defined as cell position +4 (35). CD133/prominin1 exhibits a broad expression pattern
encompassing the CBC positions through at least cell position +10 (39). Although all three of these stem
cell populations demonstrate multipotent capacity in vivo, it is unclear whether they have functionally
equivalent roles in the homeostasis of the intestinal epithelial monolayer.
We have recently shown that distinct levels of Sox9 expression mark putative IESCs based on enriched
levels of Lgr5 mRNA in discrete cell populations (14). SOX9 is a transcription factor that not only marks
stem/progenitor cells in various tissues but also has an established role in maintaining the multipotent and
proliferative capacity of stem/progenitor populations (25, 26). Using fluorescence-activated cell sorting
(FACS) of the dissociated small intestine epithelium from a Sox9  reporter gene mouse model, we
demonstrated that “low” levels of Sox9  (termed Sox9 ) mark cells that are enriched for Lgr5
(14); moreover, we identified that “high” levels of Sox9  (termed Sox9 ) mark postmitotic
enteroendocrine cells (14). Expression of endogenous levels of Sox9 mRNA and SOX9 protein were
consistent with the Sox9  and Sox9  levels, validating that the Sox9  reporter gene
faithfully recapitulates expression patterns of endogenous Sox9 (14). Although formal inducible Cre-
mediated genetic lineage tracing studies using Sox9 as a biomarker have not yet been conducted in an adult
experimental model, Cre-mediated lineage tracing during embryonic gut development suggests that Sox9
expression marks multipotent IESCs at embryonic day 17 (E17) (1). This embryonic lineage tracing study
provides compelling evidence that Sox9 expression marks a population of IESCs in the embryo that may be
conserved in the adult.
Given the CBC location and enriched Lgr5 expression in the Sox9  population, we hypothesized that
Sox9  expression marks functional IESCs. To test this hypothesis we utilized a recently described
novel in vitro assay that provides a culturing environment, which supports the generation of crypt/villus-
like structures from a single Lgr5-expressing intestinal epithelial stem cell (37). In this study we also
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Mice/genotyping.
Tissue dissociation/FACS.
characterize genetic signatures of small intestine epithelial stem/progenitor populations exhibiting different
Sox9 expression levels and explore the multipotent and self-renewal capacity of these different populations
of Sox9-expressing crypt cells. In an attempt to identify a cell surface marker that can be used to enrich for
multipotent IESCs without the requirement of a specialized fluorescent reporter gene animal model, we
investigate the coexpression pattern of Sox9  and the cluster-of-differentiation (CD) marker, CD24, a
cell surface marker that has been reported to be a putative stem cell biomarker and is easily detected by use
of widely available FACS antibodies (32, 45).
MATERIALS AND METHODS
The Sox9  mouse line was originally generated as part of the GENSAT Brain Atlas
Project (15) and contains genomic integration of a modified BAC (RP32–140D18) with 75.5 kb upstream
and 151 kb downstream sequence to Sox9. Frozen Sox9  mouse embryos were obtained from the
Mutant Mouse Regional Resource Center (University of California-Davis) and reconstituted by transfer
into foster mice. All mice are on the outbred CD-1 strain and were maintained as heterozygotes on the
CD-1 genetic background. These mice breed normally and live to adulthood with no overt phenotypes due
to the transgene. At 10 days postnatal, tail snips were viewed under an epifluorescent microscope fitted
with filters for enhanced green fluorescent protein (EGFP) visualization. A high level of EGFP
fluorescence compared with transgene-negative control mice was scored as positive for the Sox9
transgene. All protocols for animal use were reviewed and approved by the University of North Carolina
Institutional Animal Care and Use Committee.
To isolate intestinal crypt cells for FACS, small intestine epithelium was
dissociated into single cells essentially as previously described (13) with the following modifications. For
FACS experiments, mouse intestines were flushed with cold phosphate-buffered saline (PBS), cut open
lengthwise in 10-cm-long pieces, and immersed in PBS/30 mM EDTA/1.5 mM DTT over ice for 20 min.
The solution was disposed of and the tissue was shaken vigorously in fresh PBS/30 mM EDTA for 30 s
before being incubated at 37°C for 10 min. Intact tissue was discarded and dissociated crypts and villi were
pelleted at 2,500 rpm for 5 min. The cells were washed twice with cold PBS, resuspended in Hanks'
buffered saline solution (HBSS) 0.3 U/ml dispase at 37°C, and shaken approximately every 2 min for 10
min. Then fetal bovine serum (FBS, 10%) and 100 μg DNaseI were added before the cells were passed
through a 100-μm filter. Cells were pelleted at 2,500 rpm for 5 min and resuspended in 4 ml HBSS with
10% FBS, then passed through a 70-μm filter and combined with an additional 100 μg DNaseI. Equivalent
numbers of cells from three animals were combined and passed through a 30-μm filter immediately prior to
FACS.
Sox9  and CD24-expressing cells were isolated by use of a MoFlo XDP FACS machine
(Dako/Cytomation, Carpinteria, CA). Cells were collected in ice-cold Advanced DMEM/F12 supplemented
with 10 μM Y27632 (Sigma, St. Louis, MO) and kept on ice throughout the sort. Forward-side scatter
gating was used to exclude 99.8% of all dead cells and lymphocytes. Both forward scatter and side scatter
height-width plots were used for doublet discrimination to maximize efficient single cell sorting. Sort gates
for Sox9  expression were defined by previous studies (14) with the inclusion of more precise
parameters to include the Sox9  population. Cells were sorted into the medium described above.
For CD24 or CD133 staining, 1 × 10  cells were isolated as described above and were stained with 5 μl rat
anti-mouse CD24 preconjugated with Pacific blue (BioLegend, San Diego, CA) or anti-mouse CD133
preconjugated with allophycocyanin (APC) (BioLegend) in 2 ml Advanced DMEM/F12 (Invitrogen,
Carlsbad, CA) for 1 h on ice. The cells were washed twice in Advanced DMEM/F12 prior to FACS. Gate
decisions for CD24- or CD133-positive cells were made based on comparison with Pacific blue- or APC-
conjugated isotype control stained cells.
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Tissue culture.
cDNA preparation/real-time PCR analysis.
Immunostaining/microscopy.
Tissue culture methods were carried out essentially as previously described (37) with the
following modifications. FACSed cells were transferred to 2.0-ml conical tubes and pelleted at 4,500 rpm
for 5 min at 4°C before being resuspended at an approximate density of 2,000 cells/50 μl/well (24-well
plate) in Matrigel (BD Biosciences, San Jose, CA) supplemented with 1 μM JAGGED-1 peptide (AnaSpec,
San Jose, CA), 50 ng/ml EGF (R&D, Minneapolis, MN), 100 ng/ml NOGGIN (Peprotech, Rocky Hill, NJ),
and 1 μg/ml R-SPONDIN1 (R&D). All mass-per-volume growth factor concentrations were calculated in
respect to the 500-μl final volume of media per well. To facilitate ease of observation, 50-μl droplets of
Matrigel/cell suspension were added per well to 24-well plates. After total polymerization, each formed
droplet was overlaid with 500 μl Advanced DMEM/F12 containing N2 supplement (Invitrogen), B27
supplement minus vitamin A (Invitrogen), 10 mM HEPES (Invitrogen), and 10 μM Y27632 (anoikis
inhibitor). Growth factors were added every other day at the same initial concentrations, with the exception
of R-SPONDIN1, the dosage of which was reduced to 500 ng/ml for all time points following the initial
plating. Medium was replaced every 4 days. Y27632 was withdrawn at culture day 4 with the first medium
change and not included in any subsequent culture maintenance.
For passaging experiments, organoids were isolated from Matrigel with a pipette and transferred to
Advanced DMEM/F12 with 10 μM Y27632 in 2.0-ml conical tubes. Single cells were obtained by
mechanical trituration of isolated organoids followed by incubation in 0.3 U/ml dispase (BD Biosciences)
for 20 min at 37°C combined with trituration every 5 min before medium was collected and cells were
plated again in Matrigel, as described above.
cDNA from 0.75–1.0 × 10  cells from each FACSed
population (Sox9 , Sox9 , Sox9 , and Sox9 ) was made by using RNAqueous
Micro Kit (Ambion, Austin, TX) according to the manufacturer's protocols. Time between the death of the
mouse to RNA extraction was kept to 3.5–4 h to ensure the highest quality of RNA. Real-time PCR was
conducted for each sample in triplicate on 1/20,000 of the total amount of cDNA generated. Taqman
probes [18S, HS99999901; Ascl2 Mm01268891_g1; Atoh1, Mm00476035_s1; CD133 Mm00477115_m1;
CD24 Mm00782538_sH; ChgA Mm00514341_m1; cMyc Mm00487803_m1; CyclinD1 Mm03053889_s1;
S100α4 (FSP), Mm00803371_m1; Hes1, Mm00468601_m1; Lactase Mm01285112_m1; Lgr5,
Mm00438890_m1; Notch1, Mm00435245_m1; Olfm4 Mm01320260_m1; Smooth Muscle Actin (SMA),
Mm01546133_m1; Sox9, Mm00448840_m1; Substance P, Mm00436880_m1] for each gene were obtained
from Applied Biosystems (Pleasanton, CA) and used in reactions according to the manufacturer's protocol.
18S ribosomal RNA was amplified and used as the internal control gene for sample comparison. Delta
cycle threshold values were calculated to obtain fold changes for sample comparison (27). All data points
represent means ± SE from three separate experiments; statistical analysis was by one-way ANOVA and
post hoc two-sample t-tests were then performed. A P value of <0.05 is considered statistically significant.
For tissue preparation, small intestines were dissected from adult Sox9
mice (>8 wk of age) and luminal contents were flushed out with PBS followed immediately by a single
flush with freshly made 4% paraformaldehyde (PFA). The intestine was opened along the duodenal-ileal
axis, and fixed for an additional 14–18 h at 4°C. The tissues were then prepared for cryosectioning by
immersion in 30% sucrose solution for at least 24 h at 4°C. Tissues were then embedded in optimal cutting
temperature (OCT) medium and frozen on dry ice. The OCT blocks were stored at −80°C until
cryosectioning. Thin sections (8–10 μm) were cut on a cryostat and placed on positively charged
microscope slides for staining and microscopy. This tissue preparation technique is critical for preserving
the EGFP fluorescence.
Organoids were prepared for immunostaining by aspirating culture media from Matrigel cultures and fixing
entire contents of each well with 4% PFA for 14–18 h at 4°C. Following fixation, PFA was removed and
replaced with 30% sucrose solution for at least 24 h at 4°C. Organoids were then removed from Matrigel
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A cell population enriched for IESC biomarkers can be distinguished from progenitor cells based on
Sox9  levels.
with a micropipette, embedded in OCT medium, and frozen on dry ice. The OCT blocks were stored at
−80°C until cryosectioning. Thin serial sections (8–10 μm) were cut on a cryostat and placed on positively
charged microscope slides for staining and microscopy.
To remove OCT the sections were washed twice in PBS, followed by incubation in blocking medium (5%
normal goat or donkey serum, in PBS-0.3% Triton-X100) for at least 30 min at room temperature
(21–25°C). Primary antibodies were applied to the tissue sections in antibody staining solution (1% normal
goat serum, in PBS-0.3% Triton X-100). Dilutions were as follows: αCD326/EpCAM (rat, 1:1,000,
BioLegend, 118211), αLysozyme (rabbit, 1:1,000, Diagnostics Biosystems, Pleasanton, CA, RP 028),
αMucin2 (rabbit; 1:100, Santa Cruz Biotechnology, Santa Cruz, CA, sc-15334), αSOX9 (rabbit, 1:1,000,
Chemicon, Temecula, CA, AB5535), αSubstance P (rat; 1:500, Chemicon, MAB356), αsucrase isomaltase
(goat; 1:100, Santa Cruz Biotechnology, sc-27603). All secondary antibodies (αRabbit-Cy3, Sigma, St.
Louis, MO, C2306; αRabbit-Alexafluor 488, Molecular Probes, Eugene, OR, Z-25302; αRat-Alexafluor
555, Molecular Probes, Z-25305; αGoat-Cy3) were used at a 1:500 dilution in staining buffer. Nuclei were
stained with Draq5 (1:10,000, Biostatus, San Diego, CA, BOS-889-001). Background staining was
negligible as determined by nonspecific IgG staining.
Day-to-day development of organoids was tracked by light microscopy. Defects in culture plate plastic
were utilized as “landmarks” to facilitate consistent observation of developing organoids. Epifluorescence
images were captured on an Olympus IX70 fitted with an Olympus digital camera. Objective lenses used
were ×20 and ×40 with numerical apertures of 0.55 and 1.40, respectively. All confocal images represent
1.0-μm optical sections unless otherwise noted. Objective lenses for the confocal images were ×40 to ×63
with a numerical aperture of 0.1.
RESULTS
SOX9 is expressed at different levels in cells localized to the bottom region of the crypts (14, 43). Our
previous study demonstrated that high levels of SOX9 marked mature enteroendocrine cells, and that lower
levels of Sox9 marked a cell population that was enriched for the experimentally validated biomarker, Lgr5.
Our initial report regarding Sox9 expression in the small intestine crypts did not describe a third population
that can be visualized in all crypts of the small intestine by immunostaining for endogenous SOX9 and also
by Sox9  transgene expression (Fig. 1A). We have defined these cells as “sub-low” (subLo)-expressing
cells based on low but detectable levels of SOX9 and Sox9  and show that these cells localize to the
transit-amplifying progenitor cell population (Fig. 1A and Supplemental Fig. S1; the online version of this
article contains supplemental data). Using the mouse model in which Sox9 regulatory regions control
expression levels of the EGFP reporter gene, we sought to define parameters that would allow specific
separation and isolation of IESCs from progenitor populations. We reasoned that by further dividing low-
expressing Sox9  cells into two more precise categories, 1) Sox9  levels and 2) the lowest
detectable levels of Sox9 , termed Sox9 , we would potentially enrich and separate
Sox9 -expressing IESCs from Sox9  transit-amplifying cells (Fig. 1B). FACS cells based on
Sox9 , Sox9 , Sox9 , and Sox9  sort parameters demonstrated efficient
separation of the four populations of Sox9 -expressing cells (Fig. 1C).
To determine the genetic profiles of each of these populations, we conducted real-time semiquantitative RT-
PCR (sqRT-PCR) for “stemness” and lineage-specific genes. Sox9 mRNA levels were consistent with
Sox9  transgene levels, thus validating the Sox9 -based FACS (Fig. 2A). Sox9  cells show
enriched expression for the validated IESC biomarker, Lgr5, as well as the two putative IESC biomarkers,
Olfm4 and Ascl2, which have been shown to colocalize with the Lgr5 CBC population (42, 43) (Fig. 2A).
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Single Sox9  intestinal epithelial stem cells generate organoids and differentiate into Paneth
cells, enteroendocrine cells, goblet cells, and enterocytes.
Two hallmarks of stem/progenitor cell maintenance are active Wnt/β-catenin (23) and Notch-pathway
signaling (31, 44). To determine whether these two pathways were active in Sox9  cells, we assessed
the expression levels of Wnt target genes, c-Myc and CyclinD1, and also Notch1 and its downstream target,
Hes1 (Fig. 2B). Our results show increased expression of c-Myc/CyclinD1 and Notch1/Hes1 in the
Sox9  and Sox9  populations, demonstrating intact signaling of these two pathways in both
populations. Interestingly, Sox9  cells were distinguishable from Sox9  cells by marked
upregulation of Atoh1 (Math1) (Fig. 2C). Atoh1 expression is an indicator of early stem cell differentiation
into secretory lineages (46), consistent with a “progenitor cell” nature of the Sox9  population.
Analysis of the lineage-specific genes, Chromogranin A and Substance P, show that the Sox9  sort
parameters enrich for enteroendocrine cells. Increased Lactase expression in the Sox9  population
indicates this population is enriched for differentiated enterocytes (Fig. 2C). Together these results
demonstrate that FACS based on Sox9  expression levels allows for the efficient isolation and
enrichment of distinct cell populations of the small intestine epithelium. These populations include,
Sox9  enteroendocrine cells, Sox9  IESCs, Sox9  progenitors/transit-amplifying cells,
and Sox9  differentiated enterocytes.
Sox9  cells show enriched expression for established markers of multipotent IESCs, but we sought to
establish whether these cells possess functional multipotent characteristics of IESCs. To assess whether
Sox9  cells have the capacity to give rise to crypt/villus-like structures containing all four postmitotic
epithelial cell populations of the small intestine, we dissociated small intestine epithelium from Sox9
mice, isolated Sox9  cells by FACS, and plated cells into a three-dimensional (3D) culture system
that has been recently described by Sato et al. (37). A single cell was identified and followed by brightfield
and fluorescence microscopy from 24 h postplating to 19 days postplating to assess growth rate and
morphological changes (Fig. 3 and Supplemental Fig. S5). At 24 h postplating, the single cells undergo cell
division generating microcolonies, which are composed of cells that maintain Sox9  expression (
Fig. 3B). By 48 h postplating the microcolony develops a pseudolumen that is fully developed by 6 days
postplating. The pseudolumen contains dead or apoptotic cells, which were indicated by punctate, fractured
nuclear staining (data not shown), and high levels of autofluorescence. Clear segregation of cell types
expressing distinct levels of Sox9  was observed by day 9 and was coincident with the initial formation
of crypt buds, which were fully developed by days 12–16 (Fig. 3C). Two gross morphologies of
“organoids” (39) were observed, one defined by an “open” configuration where the dead and apoptotic
cells were expelled into the Matrigel, and a second defined by a “closed” confirmation where the dead and
apoptotic cells were expelled into a central luminal cavity (Fig. 3C). Organoids were allowed to grow in
culture until they either became disorganized or grew large enough to come into contact with the bottom of
the plate, which usually occurred between 16 and 20 days in culture. At this point, the organoids were
dissociated by mechanical trituration and replated into the 3D culture system. The replated cells gave rise
to multiple organoids for multiple passages (at least 6 to date), indicating the self-renewal capacity of the
IESCs within the original organoid. Single Sox9  cells were able to give rise to organoids with a well-
defined pseudolumen (days 2–6) at an average incidence of 5% (5 organoids/100 FACSed Sox9  cells
plated); however, fully formed organoids with well-defined crypt units that were present at days 12–16
were more rare and were present at an average incidence of 1%. It is important to note that upon culturing
Sox9 , Sox9 , and Sox9  cells mature organoids never formed, further validating that
Sox9  sort parameters were effectively isolating the multipotent, self-renewing IESC population.
To determine whether Sox9  cells in the organoid were able to give rise to the four postmitotic
differentiated cell types of the small intestine epithelium, we sectioned a single organoid and used
immunostaining to identify the cell lineages represented. The data indicate that cells in the organoid are
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CD24 can be used to isolate and enrich for IESCs that form organoids in culture.
epithelial in nature as demonstrated by positive immunostaining with epithelial cell adhesion molecule
(EpCAM; Fig. 4A). The three secretory lineages were represented and identified by immunostaining for
Lysozyme (Paneth cell; Fig. 4B); Substance P (enteroendocrine; Fig. 4C); and Mucin2 (goblet; Fig. 4D).
An interesting observation was that high levels of Mucin2 were present in the pseudolumen, which is
physiologically consistent with correct cellular polarity observed in normal gut function. Enterocytes were
identified by immunostaining for the brush-border enzyme sucrase isomaltase (Fig. 4E). These data
indicate that single Sox9  IESCs have the capacity to function as multipotent IESCs in culture.
One pressing question is whether contaminating mesenchymal cells, which may be attached to a
Sox9  IESCs and therefore undetectable by FACS doublet-discrimination parameters, are providing
instructive signals and mitogens to the organoids. To address this question, we visually assessed postsort
cells using fluorescence microscopy and never identified a cell aggregate containing a Sox9 -negative
cell. A more objective approach to answer this question was to section an entire organoid and immunostain
for biomarkers of fibroblasts [fibroblast-specific protein (FSP)-S100α4] and myofibroblasts [smooth
muscle actin (SMA)], the major cell types that have been proposed to support the stem cell niche and crypt
formation in vivo (21). Although tissue sections of intact small intestine demonstrated robust
immunostaining staining for fibroblast/myofibroblast markers, no staining was ever observed in 12- to 16-
day-old organoids, indicating that cells marked by SMA or S100α4 do not appear to be supporting in vitro
growth of organoids (data not shown).
To date, no cell
surface marker that can be used to FACS-isolate normal IESCs has been identified. Although investigators
have been searching for a single biomarker that exclusively marks stem cell populations, no single gene has
been demonstrated to possess this characteristic. Prevailing evidence suggests that pure stem cell
populations may be isolated from a larger pool of heterogeneous cells by using a combination of cell
surface biomarkers that produce a genetic signature for the stem cell. For example, CD markers are a class
of cell surface proteins that have been used to successfully FACS isolate multipotent stem cells from other
epithelial tissues, such as the brain, pancreas, and mammary glands (3, 29, 32, 45). One common feature of
all these epithelial stem cell populations is that CD24 is expressed on the cell surface and can be used in
combination with FACS to enrich for stem cells from the heterogeneous cell isolates. CD24 is a short
signal-transducing cell surface protein that was first characterized in B lymphocytes (17–19) and has been
since shown to be a ligand for P-selectin, an adhesion molecule found on activated platelets and endothelial
cells (34). The role of CD24 in the small intestine epithelium is currently not understood.
To explore the possibility of using CD24 as potential enrichment factor for IESCs, we conducted gene
expression analysis for CD24 by real-time sqRT-PCR on Sox9  and Sox9  FACSed cells
and compared their CD24 expression with CD24 expression in Sox9  cells (Fig. 5A). The data show
a five- to sevenfold increase in CD24 mRNA in Sox9  and Sox9  cells compared with
Sox9  cells (Fig. 5A). Likewise, flow cytometric analysis demonstrates CD24 protein is expressed in
>99% of Sox9 -positive cells (Fig. 5B). These data support the concept that CD24 is a potential
candidate biomarker for isolating and enriching IESCs from nontransgenic tissue sources.
CD24 is also present on the surface of some non-IESC types; therefore, FACS gates must be clearly
defined to specifically identify where the IESC population is located on a CD24/forward scatter FACS
histogram. Since organoids could only be generated from IESCs isolated by using Sox9  parameters,
we reasoned that Sox9  status could be used as a color-gating tool to identify where IESCs were
located on a FACS histogram with only CD24 and forward scatter as variables. Color gating is an
algorithmic feature of flow cytometry software that allows a defined parameter (such as EGFP expression
status) to be mapped back onto cells on a FACS histogram that does not contain an EGFP variable. In other
words, Sox9  cells can be recognized on a CD24 vs. forward scatter histogram to reveal where the
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Sox9  IESC population falls within CD24-expressing cells. The significance of using this strategy is
that defined sort parameters (or “sort gates”) can be specifically drawn to exclude the majority of CD24-
expressing cells that do not contain IESCs. The IESC-specific CD24 gates can then be used as a standard to
isolate and enrich for IESCs from any mouse intestinal epithelial tissue source, not just from specialized
fluorescent reporter gene mice.
Sox9  intensities (Fig. 6A, red events) that produced enrichment of IESCs and generation of
organoids were used to define sort gates on a bivariate histogram of CD24-stained intestinal epithelial cells
from a Sox9  mouse (Fig. 6, C–F, red events). A bivariate EGFP/CD24 histogram indicated there were
four discernable populations, which were used to define sort gates (CD24-high, medium, low, and negative)
(Fig. 6B). Color-gating only the Sox9  cells onto the CD24/FSC histogram shows that a majority
(60%) of all Sox9  cells fall into the CD24  gate (Fig. 6, D and F; red events) representing 19% of
all cells within the CD24  sort parameter (Figs. 6F and 7A). CD24  and CD24  gates contain
significantly less Sox9  cells, 9 and 4%, respectively. A significant number of Sox9  cells
(27%) fell in the CD24  sort parameter; however, this represented only 0.5% of all cells within that gate,
indicating a deenrichment of IESCs in the CD24  population (Figs. 6, D and F, and 7A).
As proof-of-concept, the same color-gating strategy was used to determine whether CD133, a validated
IESC marker by lineage tracing, would also be a candidate cell surface marker for the isolation of
Sox9  IESCs. CD133 has a broad expression pattern that encompasses the CBC cells up the crypt
axis to the transit-amplifying cell zone (39). sqRT-PCR and flow cytometric analyses indicate that CD133
mRNA and protein are expressed in the Sox9  and Sox9  populations (Supplemental Fig.
S2). Color gating demonstrates that the Sox9  population (94.8%) expresses CD133 on the surface;
however, the CD133-APC fluorescence shift is too low to enable significant separation of the Sox9
IESCs from CD133-negative cells (Supplemental Fig. S3). If the sort gates indicated on the CD133/FSC
histogram were used to isolate Sox9  IESCs, only 10.7% of the cells would be Sox9  cells
representing approximately half the enrichment factor compared with using CD24 as a FACS marker.
To identify which CD24 gate contained cells with functional IESC characteristics, we introduced the four
cell populations (CD24 negative, high, medium, and low) into organoid culture conditions. Organoids were
generated only from CD24  and CD24  populations at an incidence of 1:200 (CD24 ) and 1:1,000
(CD24 ) (Fig. 7, A and B). There was no overt difference in the morphology or growth between
organoids derived from cells isolated from the CD24  and CD24  gates. No organoids formed from
CD24  or CD24  populations, indicating that the cells in these two populations do not have stem cell
capacity in culture conditions. Organoids derived from CD24  and CD24  cells demonstrated
multipotency (Supplemental Fig. S4) and have been able to be expanded in culture for at least four
passages to date.
DISCUSSION
In this study, we report that Sox9  expression levels can be used to isolate IESCs that are functionally
defined by their ability to form organoids in vitro, self-renew, and contain all four postmitotic cell types of
the small intestine epithelium. Additionally, we show that distinct levels of CD24 expression enrich for
IESCs and can be used to efficiently FACS and isolate IESCs from nontransgenic intestinal tissue. CD24 is,
to our knowledge, the first reported cell surface marker that can be used to FACS isolate and enrich for
IESCs with functional characteristics.
Although we have previously reported two distinct levels of Sox9 expression in the small intestine
epithelium (14), in this study we describe a third level of Sox9 expression termed Sox9 .
Localization of Sox9  cells within the transit-amplifying zone of the crypt, FACS enrichment for
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genetic markers of dividing progenitor cells, and the lack of multipotent and self-renewal capacity of
Sox9  cells suggest that sub-low levels of Sox9 mark transit-amplifying progenitors. Using
Sox9  expression status as a cell isolation parameter will facilitate future studies on the small
intestine epithelial progenitor population.
An emerging concept in the literature is that Sox-transcription factors function in a dose-dependent manner
to affect competence, potency, and proliferation of stem and progenitor cell populations (30, 38, 41).
Results from this present study and our previous work indicate that high levels of Sox9 are associated with
nondividing cells, and a decreasing gradient of Sox9 is associated with stem/progenitor populations
characterized by increased proliferative capacities (14). The control of proliferation by Sox9 is in part
exerted through modulating Wnt/β-catenin signaling (2, 5, 14). Sox9 has been reported to be a downstream
target of Wnt signaling and appears to function by suppressing Wnt signaling in a negative feedback loop
mechanism (2, 5). High levels of transiently expressed SOX9 in a nontransformed intestinal epithelial cell
line halt proliferation indicating that SOX9 influences expression of proliferation genes (14); however, the
exact mechanism by which SOX9 exerts control of proliferation is not understood and warrants further
investigation into downstream effector genes. The ability to specifically sort the more rapidly dividing
transit-amplifying progenitor cells from the slower dividing IESCs of the small intestine epithelium will
facilitate these investigations.
The seminal study describing the culture conditions for supporting the development of IESCs in vitro
reports that single Lgr5-expressing cells are capable of building crypt-villus structures without a
mesenchymal niche (37). A fibroblastic cell component has traditionally been thought to be essential for
crypt-villus development (20, 22, 28, 40); therefore, it was interesting that stereotypical crypt-villus units
could form in the absence of a supporting cellular niche. The 3D culture conditions that facilitate crypt-
villus development in culture do, however, provide many critical components similar to those that a
mesenchymal cell might contribute to an IESC niche, including laminin enriched extracellular matrix (36),
growth factors, and Wnt agonists (37). Under culture conditions that mimic an in vivo IESC niche,
Sox9 - and CD24-expressing IESCs do not appear to require instruction from a mesenchymal cell
component to expand and build crypt-villus units in culture. Immunostaining for SMA or FSP failed to
demonstrate positive staining in serial sections through Sox9  IESC-derived organoids (data not
shown). To rule out the possibility that identification of a small population of fibroblasts and/or
myofibroblasts was beyond the threshold of detection of the immunostaining technology, we conducted
sqRT-PCR on RNA isolated from both isolated crypts and postsorted Sox9  cells. sqRT-PCR analysis
also failed to detect SMA or FSP from either sample after 40 cycles of PCR, indicating that there is no
detectable contamination of a fibroblastic cell in the FACS-sorted cells (data not shown). These data
provide strong evidence that generation of crypt-villus units derived from Sox9  cells do not require a
fibroblastic cell component. This is consistent with the proposal that in this 3D culture system IESCs are
able to generate a crypt-villus axis by differential intrinsic responsiveness of intestinal epithelial cells to
Wnt signals rather than from extrinsic stimuli (37).
To date, FACS of single IESCs that express experimentally validated markers of IESCs has required a
specialized transgenic reporter-gene mouse expressing a fluorescent protein (4, 14). A previously reported
method for isolation of a putative IESC population from nontransgenic mice was via side population (SP)
sorting (12). Although the SP faction was shown to be from the crypt base, and to be enriched for putative
IESC markers (16), SP cells have not been demonstrated to be capable of either replication or
differentiation. We report here that CD24 is a cell surface biomarker that can be used to FACS enrich for
cells with functional IESC characteristics (multipotency and self-renewal), and possess the ability to form
crypt/villus-like units in vitro from a nontransgenic mouse. Low CD24 expression has been used as a
marker to FACS isolate stem cells from the pancreas, brain, and mammary tissue (3, 29, 32, 34, 45). The
expression pattern of CD24 in the normal small intestine epithelium is unknown; however, there are reports
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that CD24 is associated with epithelial cells in colonic adenocarcinomas (24, 33). With CD24 used as a
FACS biomarker for IESCs, organoids only developed from cells isolated from CD24  and CD24  gates
with an incidence of 0.5 and 0.1%, respectively. This represents a 2- to 10-fold reduction in organoid
formation compared with using Sox9  expression alone as the sort parameter.
Recent lineage-tracing studies in mice suggest that CD133 expression marks a subset of crypt cells that
exhibit IESC characteristics (39). The use of CD133 as a cell surface marker for FACS enrichment of these
IESCs was not tested in this study. Our data suggest that CD133 is not an efficient cell surface marker for
enrichment of murine IESCs with antibody reagents currently available (Supplemental Fig. S3). Putative
IESCs marked by low levels of Sox9  did exhibit expression of CD133 mRNA and protein
(Supplemental Fig. S2); however, flow cytometry indicated that CD133 expression levels appeared to be
below a threshold that would allow separation and enrichment by FACS (Supplemental Fig. S3).
Although the most rigorously validated biomarkers Lgr5, Bmi1, CD133, and Sox9 appear to mark IESC
populations, none of these markers has been shown exclusively to mark IESCs. For instance, like
Sox9 , Lgr5  is expressed at high and low levels in the crypt base. It was demonstrated that low-
expressing Lgr5  cells rarely gave rise to organoids (37), suggesting that Lgr5 also marks a non-IESC
population. Furthermore, only 6% of Lgr5  cells demonstrated self-renewal and multipotent capacity
(37). Although the low number of Lgr5  cells demonstrating functional IESC characteristics could be
the result of isolation and culture conditions, it is also possible that not all of these cells are IESCs. We
propose that a combinatorial approach using multiple genetic markers will provide a more robust genetic
signature for the IESC and allow for a more pure population of IESCs to be isolated by FACS. In this
regard, we used CD24- and CD133 antibodies to costain crypt cell preparations with the goal of further
identifying a more pure population of IESCs. After mapping the Sox9  cells back onto the CD24 vs.
CD133 histogram there was no further enrichment of the Sox9  cells or any unique cell population
compared with using CD24-antibody alone (data not shown). This result might be due to the low
fluorescent signature of the CD133-stained cells. To rule out the possibility that CD133 can be used an
efficient IESC enrichment marker in mice, a more robust CD133 antibody must be developed. As this study
demonstrates, the Sox9  mouse model combined with color-gating flow cytometry provides a powerful
tool to screen other known and uncharacterized cell surface markers for their capacity to mark the IESC
population. The ability to use CD24 as an IESC enrichment factor represents a new and transformative
approach to IESC isolation, as well as to the study of IESC maintenance, expansion, and differentiation.
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Fig. 1.
Open in a separate window
Sox9  is expressed at 3 different levels in the small intestinal epithelium. A: Sox9  is expressed at variable levels,
“HI,” “LO,” and “subLO,” in the crypts of the small intestine. HI levels are associated with postmitotic enteroendocrine
cells, LO levels are associated with crypt-base columnar cells, “subLO” levels are associated with the transit-amplifying
region of the crypt, and NEG levels are Sox9  negative. Images represent ×1,260 original magnification. B: flow
cytometric analysis indicates distinct Sox9  expression levels. Gate parameters used to sort each population are
indicated above each region of the histogram. C: postsort analysis indicates that single Sox9 -expressing cells have
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been isolated based on enhanced green fluorescent protein (EGFP) status. Images represent ×200 original magnification.
The image exposures for Sox9  and Sox9  panels were doubled to produce images that would allow
visualization of EGFP expression in these 2 populations.
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Fig. 2.
Gene expression analysis demonstrates isolation and enrichment of intestinal epithelial stem cells (IESCs), progenitors,
and enteroendocrine cells by use of fluorescence-activated cell sorting (FACS). Semiquantitative RT-PCR conducted on
FACSed NEG, subLO, LO, and HI cells demonstrates enrichment of IESC stem cell biomarkers in the LO populations (A),
active Wnt/β-catenin and Notch1 signaling in subLO and LO populations (B), and enrichment of committed secretory
progenitors in the subLO population and enteroendocrine cells in the HI population (C). Elevated lactase expression in the
NEG population indicates this population is enriched for enterocytes. All data points represent means ± SE from 3
independent experiments; statistical analysis was by ANOVA and post hoc 2 sample t-tests were then performed. A P
value <0.05 is considered statistically significant. Different letters above each bar represent data points that are statistically
different from each other.
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Fig. 3.
Single Sox9  cells form complex organoids in vitro. A: single cells develop into large aggregates with crypt and
villus-like structures over 7–10 days. The central pseudolumens of the single-cell-derived organoids expel apoptotic cells
resulting from the sloughing of terminally differentiated epithelial cells. Arrows mark defects in culture plastic used as
“landmarks” to track individual cells through early developmental phases into formed organoids. At day 9 the organoid
grew large enough to obscure the tracking defects; therefore, additional tracking marks were identified (white arrows). B:
epifluorescent images of organoids depicted in A. Note that the green pseudolumen is nonspecific autofluorescence and not
EGFP fluorescence. Differential Sox9  expression patterning remains evident throughout expansion in vitro. C:
organoids form both open and closed morphologies, based on developmental positioning of the apoptotic pseudolumen.
Apoptotic cells slough openly into Matrigel in the “open” morphology and are seen as a dense, dark region in the “closed”
morphology. Ages of organoids are 12 days postsort (top) and 15 days postsort (bottom). Organoids are magnified ×300
(top) and ×200 (bottom).
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Fig. 4.
Sox9  cells are capable of differentiation into all postmitotic cell types associated with the intestinal epithelium. A:
epithelial cell adhesion molecule (EpCAM) staining indicates organoids cells are epithelial. B: lysozyme marks Paneth
cells near the base of cryptlike structures. C: enteroendocrine cells are labeled with Substance P and also restricted to the
base of cryptlike structures in the organoids. D: Mucin2 demonstrates the goblet cell phenotype in cryptlike structures.
Secreted Mucin2 in the pseudolumen suggests that goblet cells are correctly polarized. E: sucrase isolmaltase (SIM) labels
the apical ends of enterocytes lining the pseudolumen in the organoids. White boxes in the far left images (×100 original
magnification) represent areas magnified in the center 2 columns (×800 original magnification). White arrows point to
representative cells. Associated expression patterns in vitro correlate with those observed in vivo (far right). The organoid
represented was cultured for 12 days.
EGFPlo
Sox9 expression marks a subset of CD24-expressing small intestine epith... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867430/?report=printable
19 of 22 1/16/2019, 11:27 AM
Fig. 5.
Small intestine epithelial stem/progenitor cells express CD24 mRNA and protein. A: semiquantitative RT-PCR (sqRT-
PCR) demonstrates that CD24 is expressed 5.5- to 7.2-fold higher in the subLO and LO cells compared with Sox9 -
negative cells. All data points represent means ± SE from 3 independent experiments; statistical analysis was by ANOVA,
and post hoc 2-sample t-tests were then performed. A P value <0.05 is considered statistically significant. Different letters
above each bar represent data points that are statistically different from each other. B: flow cytometric analysis indicates
that nearly all Sox9 -positive cells express CD24 protein. Left: Pacific blue-conjugated isotype antibody control.
αCD24-Pacific blue conjugated antibody. Right: gray brackets in the histograms represent the FACS gating parameters.
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Fig. 6.
Flow cytometric analysis shows that a majority Sox9  cells fall within CD24  expression pattern. A: Sox9
expression of dissociated small intestine epithelial cells on a univariate EGFP histogram. Black brackets indicate gate
parameters. Color gating (red) allows visualization of Sox9  population in histograms A–F. B: Sox9 /CD24
bivariate histogram used to define the 4 CD24 gate parameters [negative (NEG), low (LO), medium (MED), and high
(HI)]. C and E: IgG control antibody indicates there is no significant nonspecific staining. D and F: αCD24-PB (Pacific
blue) antibody labels 73% of Sox9  cells. D: percentages represent the number of Sox9 -expressing cells in
each gate. Mean percentage ± SE for each population are as follows: NEG, 1.67 ± 0.25%; LO, 25.63 ± 0.95%; MED,
12.23 ± 1.48%; HI, 9.33 ± 0.91%. E and F: just Sox9  cells color backgated onto the CD24/FSC histogram to
highlight their distribution on the histogram. F: percentages represent the relative number of all Sox9  cells in each
gate. Mean percentage ± SE for each population are as follows: NEG, 50.7 ± 5.37%; LO, 42.47 ± 4.34%; MED, 10.23 ±
1.16%; HI, 0.50 ± 0.00%.
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Fig. 7.
Open in a separate window
CD24 can be used as a biomarker to isolate and enrich for single cells capable of producing sustainable, differentiated
organoids. A: table representing the enrichment of putative IESCs by using CD24 expression levels as sort criterion.
Percent Sox9  cells/gate = number of Sox9  cells/total number of cells per gate. Fold enrichment, percent
Sox9  cells per gate/percent Sox9  cells in all sorted cells. CD24  sort parameters demonstrate the highest
potential for enrichment of IESCs. There is a ×25.1 enrichment for Sox9  cells in the CD24  sort parameters
compared with ungated cells. Organoid generating IESCs can be isolated only with the CD24  (5 organoids in every 1,000
cells) and CD24  (1 organoid in every 1,000 cells) sort parameters. B: representative organoids derived from single
CD24 -expressing cells (left, day 9; right, day 13).
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